SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation -- Ignore unavailable to you. Want to Upgrade?


To: IRWIN JAMES FRANKEL who wrote (101)8/20/2001 5:58:40 PM
From: scaram(o)uche  Read Replies (2) | Respond to of 631
 
That's a big increase in the number of infections. I didn't see an indication of dropouts, so let's assume that it's 26 of 56 patients that got rhino- or adeno-like infections in the trial (versus 13 or 14 of 56 for placebo).

To me, bad omen.

The result in psoriasis looks very good to me.

Me too.